Canopy Growth Corp Stock Today
| CGC Stock | USD 1.24 0.05 3.88% |
PerformanceInsignificant
| Odds Of DistressVery High
|
Canopy Growth is trading at 1.24 as of the 22nd of June 2025, a 3.88% down since the beginning of the trading day. The stock's open price was 1.29. Canopy Growth has a very high chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. The performance scores are derived for the period starting the 3rd of July 2023 and ending today, the 22nd of June 2025. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 4th of April 2014 | Category Healthcare | Classification Health Care |
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada. The company has 186.89 M outstanding shares of which 17.67 M shares are currently shorted by investors with about 2.3 days to cover. More on Canopy Growth Corp
Moving together with Canopy Stock
| 0.66 | KG | KING PHARMACEUTICALS INC Symbol Change | PairCorr |
Moving against Canopy Stock
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores
Canopy Stock Highlights
| CEO Director | Luc Mongeau | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Thematic Idea | Cannabis (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Old Names | [Aris Gold Corporation, CHINA GREEN (HLDGS), CHINA GREEN (HLDGS) - Frankfurt Stock Exchang, CHINA GREEN (HLDGS), CHINA GREEN (CGC.SG), Costa Group Holdings Ltd] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Australia All Ordinaries, NASDAQ Composite, NASDAQ Health Care, SPASX 200, Cannabis, Health Care, Pharmaceuticals, Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsCanopy Growth can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Canopy Growth's financial leverage. It provides some insight into what part of Canopy Growth's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Canopy Growth Corp (CGC) is traded on NASDAQ Exchange in USA. It is located in 1 Hershey Drive, Smiths Falls, ON, Canada, K7A 0A8 and employs 960 people. Canopy Growth is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a total capitalization of 275.69 M. Canopy Growth Corp runs under Pharmaceuticals sector within Health Care industry. The entity has 186.89 M outstanding shares of which 17.67 M shares are currently shorted by investors with about 2.3 days to cover.
Canopy Growth Corp has about 1.23 B in cash with (164.8 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.94, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Canopy Growth Probability Of Bankruptcy
Ownership AllocationCanopy Growth holds a total of 186.89 Million outstanding shares. Almost 90.8 percent of Canopy Growth outstanding shares are held by general public with 0.94 (percent) owned by insiders and only 8.26 % by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Canopy Ownership Details
Canopy Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Virtu Financial Llc | 2025-03-31 | 280.1 K | |
| Two Sigma Securities, Llc | 2025-03-31 | 268.9 K | |
| Group One Trading, Lp | 2025-03-31 | 154.2 K | |
| Baader Bank Inc | 2025-03-31 | 153.9 K | |
| Wealthfront Advisers Llc | 2024-12-31 | 139.2 K | |
| Td Asset Management Inc | 2025-03-31 | 112.7 K | |
| Ameriprise Financial Inc | 2025-03-31 | 107.9 K | |
| Advisorshares Investments, Llc | 2025-03-31 | 91.5 K | |
| Sig North Trading, Ulc | 2025-03-31 | 75.9 K | |
| Tidal Investments Llc. | 2025-03-31 | 3.8 M | |
| Millennium Management Llc | 2025-03-31 | 1.8 M |
Canopy Growth Historical Income Statement
Canopy Stock Against Markets
Canopy Growth Corporate Management
| Mark Ware | Chief Medical Officer | Profile | |
| Terry Yanofsky | Director | Profile | |
| FCPA FCA | Strategic Advisor | Profile | |
| Robert Hanson | Independent Director | Profile |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Canopy Growth Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Canopy Growth. If investors know Canopy will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Canopy Growth listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.14) | Revenue Per Share | Quarterly Revenue Growth (0.11) | Return On Assets | Return On Equity |
The market value of Canopy Growth Corp is measured differently than its book value, which is the value of Canopy that is recorded on the company's balance sheet. Investors also form their own opinion of Canopy Growth's value that differs from its market value or its book value, called intrinsic value, which is Canopy Growth's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Canopy Growth's market value can be influenced by many factors that don't directly affect Canopy Growth's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Canopy Growth's value and its price as these two are different measures arrived at by different means. Investors typically determine if Canopy Growth is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Canopy Growth's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.